Health Disparities in the Treatment of Supraventricular Tachycardia in Pediatric Patients

• Published in: Pediatric cardiology 2022-12, Vol.43 (8), p.1857-1863
• Main Authors: Sooy-Mossey, Meredith, Neufeld, Thomas, Hughes, Taylor L., Weiland, M. David, Spears, Tracy G., Idriss, Salim F., Campbell, Michael J.
• Format: Article
• Language: English
• Subjects: Ablation (Surgery); Adolescent; Cardiac patients; Cardiac Surgery; Cardiology; Catheter Ablation - methods; Child; Child, Preschool; Children; Congenital heart disease; Drug therapy; Female; Genetic disorders; Health aspects; Heart Defects, Congenital - surgery; Humans; Medical centers; Medical colleges; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Native Americans; Original Article; Pediatrics; Retrospective Studies; Supraventricular tachycardia; Tachycardia, Supraventricular - diagnosis; Tachycardia, Supraventricular - surgery; Treatment Outcome; Vascular Surgery
• ISSN: 0172-0643; 1432-1971; 1432-1971
• DOI: 10.1007/s00246-022-02924-x

Supraventricular tachycardia (SVT) is a common pediatric arrhythmia. The objective of this investigation was to investigate the existence and degree of the health disparities in the treatment of pediatric patients with supraventricular tachycardia based on sociodemographic factors. This was retrospective cohort study at a large academic medical center including children ages 5–18 years old diagnosed with SVT. Patients with congenital heart disease and myocarditis were excluded. Initial treatment and ultimate treatment with either medical management or ablation were determined. The odds of having an ablation procedure were determined based on patient age, sex, race, ethnicity, and insurance status. There was a larger portion of non-White patients ( p  = 0.033) within the cohort that did not receive an ablation during the study period. Patients that were younger, female, American Indian/Alaskan Native, unknown race, and had missing insurance information were less likely to receive ablation therapy during the study period. In this single center, regional evaluation, we demonstrated that disparities in the treatment of pediatric SVT are present based on multiple patient sociodemographic factors. This study adds evidence to the presence of inequities in health care delivery across pediatric populations.